Lemon Balm — Research Profile

Cyracos is a patented lemon balm extract standardized to contain greater than 7% rosmarinic acid and greater than 15% hydroxycinnamic acid derivatives. It was developed by Naturex and used in the Cases et al. (2011) clinical study that showed a 49% reduction in anxiety and 39% reduction in insomnia. Cyracos is considered one of the better-studied forms of lemon balm and is available in several commercial supplement brands.

Yes — lemon balm has been shown in laboratory studies to inhibit TSH (thyroid-stimulating hormone) binding and may reduce thyroid hormone production. People with hypothyroidism or those taking thyroid medication should use lemon balm with caution and consult their healthcare provider. For people with normal thyroid function, standard supplement doses are unlikely to cause clinically significant thyroid effects.

Lemon balm is effective for both, but its strongest evidence is for anxiety-related insomnia — it addresses the underlying anxiety that prevents sleep ^[1][2][6]. For pure sleep support without anxiety, valerian or melatonin may be more appropriate. Lemon balm is particularly useful for people whose sleep difficulties stem from a racing mind or stress, as it calms mental chatter without heavy sedation ^[2][4].

Human trials used oral standardized leaf extracts in capsules (such as Cyracos) or encapsulated dried leaf, and these are the forms with efficacy data behind them. Acute cognition and stress studies used dried leaf or extract at 300-1600 mg, while teas deliver a variable and generally lower dose of the active phenolics. Lemon balm essential oil is intended for aromatherapy and is not an oral-dose equivalent of the leaf extracts studied for anxiety.

The strongest signal is for anxiety and mood: a meta-analysis of clinical trials found significant reductions in anxiety (standardized mean difference -0.98) and depression symptoms (SMD -0.47) versus placebo, and acute dosing reliably increases self-rated calmness. Metabolic effects are more modest, with meta-analyses showing small reductions in total cholesterol, triglycerides, and LDL, plus lower total cholesterol and systolic blood pressure, but no change in blood glucose. All of these findings come from small, heterogeneous trials, so they are promising rather than definitive.

There is no official recommended dose. Anxiety and sleep trials most commonly used 300-600 mg/day of standardized leaf extract, with the Cyracos protocol splitting 600 mg into 300 mg at breakfast and 300 mg at dinner. Acute stress and cognition studies used single doses of 600-1600 mg of dried leaf, and the overall trial range spans roughly 80-1200 mg/day, so starting at the lower standardized-extract end is reasonable.

Time of day has not been directly compared head-to-head in trials. The Cyracos anxiety-and-sleep protocol split the dose between breakfast and dinner, while people using it for sleep typically take it in the evening. Because a single dose raises calmness within about an hour, dosing ahead of a predictable stressor is a practical approach.

Lemon balm is well tolerated in trials, with most reporting no adverse events; occasional mild effects include headache and flatulence that resolved. The most predictable dose-related effect is sedation, since 600 mg increased calmness and reduced alertness compared with placebo, which can feel like drowsiness. No serious adverse events were reported across the anxiety, depression, and cardiometabolic trials reviewed.

Dedicated human drug-interaction studies are lacking, so the main concern is mechanistic: lemon balm enhances GABA signaling (its rosmarinic acid inhibits GABA transaminase), which could add to the effect of sedatives, benzodiazepines, sleep medications, and alcohol. A theoretical interaction with thyroid function has been raised from laboratory work but is not confirmed in people. Anyone on central-nervous-system depressants or scheduled for surgery should treat the additive-sedation risk as the realistic caution.

The best evidence supports adults with mild-to-moderate anxiety, everyday stress, or mild sleep disturbance, where standardized extract reduced anxiety and insomnia scores; a single non-blinded trial also found it comparable to antidepressants for milder depression. It is not established for pregnancy, breastfeeding, or children under 2, as these groups have not been adequately studied. People wanting a gentle, short-course calming aid are the clearest candidates, rather than those seeking a treatment for diagnosed metabolic disease.

A single 300-600 mg dose of standardized leaf extract can raise self-rated calmness within about 1 hour, and acute mood and cognition studies measured effects at 1 to 6 hours post-dose. For anxiety and sleep, benefits build over days: an open-label trial of 600 mg/day of a standardized extract (Cyracos) recorded an 18% drop in anxiety and a 42% drop in insomnia scores over 15 days. Controlled depression and anxiety trials generally ran several weeks, so daily use over a few weeks is a fairer test than a single dose.

Most controlled trials lasted only 1 to 8 weeks, with one dementia study extending to 48 weeks, and these reported low dropout and no significant adverse events on bloodwork or ECG. There is no established maximum safe duration, and reviewers note that safety of daily use beyond roughly 56 days has not been well characterized. That makes lemon balm reasonable for defined courses, but open-ended year-round dosing rests on limited long-term data.

No tolerable upper limit has been set for lemon balm. Human trials have used doses from about 80 mg up to 5000 mg per day without serious toxicity, though effects above 5000 mg/day are not established. Because the extract is mildly sedating, the most likely consequence of an excessive dose is drowsiness and reduced alertness rather than acute organ toxicity.

Lemon balm is frequently paired with other calming botanicals such as valerian, but combining does not guarantee benefit: a 6-week trial of L-theanine plus lemon balm, valerian, and saffron did not improve objective or subjective sleep more than placebo. Since lemon balm itself is mildly sedating, stacking it with other sedative herbs can add to drowsiness. There is no evidence a particular supplement combination outperforms a standardized lemon balm extract used on its own.

Choose a product that names Melissa officinalis leaf and is standardized to its active phenolics, chiefly rosmarinic acid and related hydroxycinnamic acids, since that is the fraction linked to GABAergic and calming activity. The best anxiety and sleep evidence used a specific standardized leaf extract (Cyracos) at 600 mg/day, so a defined extract with a stated marker content is preferable to generic "lemon balm powder" of unknown potency. No single standardization percentage is mandated across the industry, making a third-party quality certification worthwhile.